Inactive Instrument
Ocata Therapeutics Inc Stock
Stocks
US67457L1008
Biotechnology & Medical Research
|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| Manager | Title | Age | Since |
|---|---|---|---|
John Heffernan
PRN | Corporate Officer/Principal | - | 2015-02-02 |
| Director | Title | Age | Since |
|---|---|---|---|
Toru Yoshimitsu
BRD | Director/Board Member | 63 | - |
Masaaki Hirano
BRD | Director/Board Member | 59 | - |
| Director/Board Member | 53 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.11% | -1.68% | +43.40% | +95.27% | 66.93B | |
| -0.23% | -4.45% | +32.50% | +75.75% | 61.97B | |
| +1.67% | +2.47% | -11.32% | +380.54% | 28.26B | |
| -1.05% | -4.43% | +28.84% | +10.59% | 24.59B | |
| +0.34% | -6.78% | -0.01% | -16.35% | 24.3B | |
| +0.43% | -3.37% | +16.22% | -17.99% | 19.41B | |
| -3.03% | -2.29% | +181.72% | +335.27% | 16.77B | |
| -1.94% | -4.94% | -8.15% | +483.69% | 14.18B | |
| +3.24% | -0.31% | -7.34% | +880.45% | 14B | |
| Average | -0.30% | -2.95% | +30.65% | +247.47% | 30.05B | |
| Weighted average by Cap. | -0.56% | -2.83% | +31.25% | +170.65% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
